CDK6 is essential for mesenchymal stem cell proliferation and adipocyte differentiation

Background: Overweight or obesity poses a significant risk of many obesity-related metabolic diseases. Among all the potential new therapies, stem cell-based treatments hold great promise for treating many obesity-related metabolic diseases. However, the mechanisms regulating adipocyte stem cells/progenitors (precursors) are unknown. The aim of this study is to investigate if CDK6 is required for mesenchymal stem cell proliferation and adipocyte differentiation. Methods: Cyclin-dependent kinase 6 (Cdk6) mouse models together with stem cells derived from stromal vascular fraction (SVF) or mouse embryonic fibroblasts (MEFs) of Cdk6 mutant mice were used to determine if CDK6 is required for mesenchymal stem cell proliferation and adipocyte differentiation. Results: We found that mice with a kinase inactive CDK6 mutants (K43M) had fewer precursor residents in the SVF of adult white adipose tissue (WAT). Stem cells from the SVF or MEFs of K43M mice had defects in proliferation and differentiation into the functional fat cells. In contrast, mice with a constitutively active kinase CDK6 mutant (R31C) had the opposite traits. Ablation of RUNX1 in both mature and precursor K43M cells, reversed the phenotypes. Conclusion: These results represent a novel role of CDK6 in regulating precursor numbers, proliferation, and differentiation, suggesting a potential pharmacological intervention for using CDK6 inhibitors in the treatment of obesity-related metabolic diseases.

[1]  Siyao Cheng,et al.  CDK6 increases glycolysis and suppresses autophagy by mTORC1-HK2 pathway activation in cervical cancer cells , 2022, Cell cycle.

[2]  Michael T. McManus,et al.  CD81 Controls Beige Fat Progenitor Cell Growth and Energy Balance via FAK Signaling , 2020, Cell.

[3]  H. Sacks,et al.  Caffeine exposure induces browning features in adipose tissue in vitro and in vivo , 2019, Scientific Reports.

[4]  Hancheng Li,et al.  Human Umbilical Cord Mesenchymal Stem Cells Therapy for Insulin Resistance: A Novel Strategy in Clinical Implication. , 2018, Current stem cell research & therapy.

[5]  Yongsheng Fan,et al.  CDK6 inhibits white to beige fat transition by suppressing RUNX1 , 2018, Nature Communications.

[6]  Xiaoling Hu,et al.  Concise Review: Quantitative Detection and Modeling the In Vivo Kinetics of Therapeutic Mesenchymal Stem/Stromal Cells , 2017, Stem cells translational medicine.

[7]  Y. Mu,et al.  Human umbilical cord-derived mesenchymal stem cells ameliorate insulin resistance by suppressing NLRP3 inflammasome-mediated inflammation in type 2 diabetes rats , 2017, Stem Cell Research & Therapy.

[8]  S. Gygi,et al.  The metabolic function of cyclin D3–CDK6 kinase in cancer cell survival , 2017, Nature.

[9]  S. Mudaliar,et al.  Efficacy of Autologous Bone Marrow-Derived Mesenchymal Stem Cell and Mononuclear Cell Transplantation in Type 2 Diabetes Mellitus: A Randomized, Placebo-Controlled Comparative Study. , 2017, Stem cells and development.

[10]  M. Malumbres,et al.  A Kinase-Independent Function of CDK6 Links the Cell Cycle to Tumor Angiogenesis , 2016, Cancer cell.

[11]  G. Hu,et al.  CDK6-mediated repression of CD25 is required for induction and maintenance of Notch1- induced T cell acute lymphoblastic leukemia , 2015, Leukemia.

[12]  K. Chan,et al.  RUNX1 is essential for mesenchymal stem cell proliferation and myofibroblast differentiation , 2014, Proceedings of the National Academy of Sciences.

[13]  P. Hinds,et al.  Cyclin D1 activity regulates autophagy and senescence in the mammary epithelium. , 2012, Cancer research.

[14]  M. Kassem,et al.  Mouse Embryonic Fibroblasts (MEF) Exhibit a Similar but not Identical Phenotype to Bone Marrow Stromal Stem Cells (BMSC) , 2012, Stem Cell Reviews and Reports.

[15]  M. Montecino,et al.  Runx1 and C/EBPβ transcription factors directly up‐regulate P2X3 gene transcription , 2012, Journal of cellular physiology.

[16]  P. Larsen,et al.  Targeted deletion of thioesterase superfamily member 1 promotes energy expenditure and protects against obesity and insulin resistance , 2012, Proceedings of the National Academy of Sciences.

[17]  M. Lazar,et al.  Forming functional fat: a growing understanding of adipocyte differentiation , 2011, Nature Reviews Molecular Cell Biology.

[18]  G. Hu,et al.  CDK6 kinase activity is required for thymocyte development. , 2011, Blood.

[19]  L. Nguyen,et al.  Cdk6‐Dependent Regulation of G1 Length Controls Adult Neurogenesis , 2011, Stem cells.

[20]  B. Spiegelman,et al.  Prdm16 determines the thermogenic program of subcutaneous white adipose tissue in mice. , 2011, The Journal of clinical investigation.

[21]  L. Hennighausen,et al.  Essential role for Stat5a/b in myeloproliferative neoplasms induced by BCR-ABL1 and JAK2(V617F) in mice. , 2009, Blood.

[22]  G. Hu,et al.  A requirement for cyclin-dependent kinase 6 in thymocyte development and tumorigenesis. , 2009, Cancer research.

[23]  J. Gimble,et al.  Flow cytometric and immunohistochemical detection of in vivo BrdU-labeled cells in mouse fat depots. , 2009, Biochemical and biophysical research communications.

[24]  J. Friedman,et al.  Identification of White Adipocyte Progenitor Cells In Vivo , 2008, Cell.

[25]  A. Ferrando,et al.  Oncogenic NOTCH1 Control of MYC and PI3K: Challenges and Opportunities for Anti-NOTCH1 Therapy in T-Cell Acute Lymphoblastic Leukemias and Lymphomas , 2008, Clinical Cancer Research.

[26]  Caroline L. Speck,et al.  Runx1-mediated hematopoietic stem-cell emergence is controlled by a Gata/Ets/SCL-regulated enhancer. , 2007, Blood.

[27]  A. Friedman,et al.  Cyclin-dependent kinase phosphorylation of RUNX1/AML1 on 3 sites increases transactivation potency and stimulates cell proliferation. , 2007, Blood.

[28]  W. Stanford,et al.  Concise Review: Stem Cell Antigen‐1: Expression, Function, and Enigma , 2007, Stem cells.

[29]  C. Nerlov,et al.  Cdk6 blocks myeloid differentiation by interfering with Runx1 DNA binding and Runx1‐C/EBPα interaction , 2007, The EMBO journal.

[30]  B. Lim,et al.  Identification of Common Pathways Mediating Differentiation of Bone Marrow‐ and Adipose Tissue‐Derived Human Mesenchymal Stem Cells into Three Mesenchymal Lineages , 2007, Stem cells.

[31]  D. Klemm,et al.  Rosiglitazone promotes development of a novel adipocyte population from bone marrow-derived circulating progenitor cells. , 2006, The Journal of clinical investigation.

[32]  J. Biggs,et al.  AML1/RUNX1 Phosphorylation by Cyclin-Dependent Kinases Regulates the Degradation of AML1/RUNX1 by the Anaphase-Promoting Complex , 2006, Molecular and Cellular Biology.

[33]  W. Pear,et al.  Notch1 promotes survival of E2A-deficient T cell lymphomas through pre-T cell receptor-dependent and -independent mechanisms. , 2006, Blood.

[34]  M. Barbacid,et al.  Cdk4 promotes adipogenesis through PPARgamma activation. , 2005, Cell metabolism.

[35]  F. Gounari,et al.  Loss of adenomatous polyposis coli gene function disrupts thymic development , 2005, Nature Immunology.

[36]  M. Lane,et al.  From multipotent stem cell to adipocyte. , 2005, Birth defects research. Part A, Clinical and molecular teratology.

[37]  Pierre Dubus,et al.  Mammalian Cells Cycle without the D-Type Cyclin-Dependent Kinases Cdk4 and Cdk6 , 2004, Cell.

[38]  P. A. Tataranni,et al.  Subcutaneous abdominal preadipocyte differentiation in vitro inversely correlates with central obesity. , 2004, American journal of physiology. Endocrinology and metabolism.

[39]  K. Kristiansen,et al.  Retinoblastoma protein functions as a molecular switch determining white versus brown adipocyte differentiation , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[40]  P. Leder,et al.  Tracing lymphopoiesis with the aid of a pTα-controlled reporter gene , 2002, Nature Immunology.

[41]  H. Linhart,et al.  C/EBPα is required for differentiation of white, but not brown, adipose tissue , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[42]  P. Carlsson,et al.  FOXC2 Is a Winged Helix Gene that Counteracts Obesity, Hypertriglyceridemia, and Diet-Induced Insulin Resistance , 2001, Cell.

[43]  H. Lorenz,et al.  Multilineage cells from human adipose tissue: implications for cell-based therapies. , 2001, Tissue engineering.

[44]  P. Puigserver,et al.  Transcriptional regulation of adipogenesis. , 2000, Genes & development.

[45]  K. Chien,et al.  PPARγ Is Required for Placental, Cardiac, and Adipose Tissue Development , 1999 .

[46]  N. Pavletich.  Mechanisms of cyclin-dependent kinase regulation: structures of Cdks, their cyclin activators, and Cip and INK4 inhibitors. , 1999, Journal of molecular biology.

[47]  K. Kristiansen,et al.  Activation of Peroxisome Proliferator-activated Receptor γ Bypasses the Function of the Retinoblastoma Protein in Adipocyte Differentiation* , 1999, The Journal of Biological Chemistry.

[48]  J. Gimble,et al.  CAAT/enhancer binding proteins directly modulate transcription from the peroxisome proliferator-activated receptor gamma 2 promoter. , 1997, Biochemical and biophysical research communications.

[49]  M. Lazar,et al.  Peroxisome Proliferator Activated Receptor γ, CCAAT/ Enhancer-binding Protein α, and Cell Cycle Status Regulate the Commitment to Adipocyte Differentiation* , 1997, The Journal of Biological Chemistry.

[50]  Z. Wu,et al.  Conditional ectopic expression of C/EBP beta in NIH-3T3 cells induces PPAR gamma and stimulates adipogenesis. , 1995, Genes & development.

[51]  J. Hirsch,et al.  Adipose tissue cellularity in human obesity. , 1976, Clinics in endocrinology and metabolism.

[52]  M. Lane,et al.  Adipogenesis: from stem cell to adipocyte. , 2012, Annual review of biochemistry.

[53]  Kanika Jain,et al.  Isolation and handling of mouse embryonic fibroblasts. , 2014, Methods in molecular biology.

[54]  F. Guilak,et al.  Differentiation of adipose stem cells. , 2008, Methods in molecular biology.

[55]  F. Guilak,et al.  Adipose-derived adult stem cells: isolation, characterization, and differentiation potential. , 2003, Cytotherapy.